Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Acino Pharma (Pty) Ltd

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Acino Pharma (Pty) Ltd

Country
2024 ACI Convention
Not Confirmed
arrow

Acino Pharma (Pty) Ltd

Country
arrow
2024 ACI Convention
Not Confirmed

Natalizumab

Brand Name : Tysabri

Dosage Form : INF

Dosage Strength : 20mg/ml

Packaging : 15X1mg/ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank